Showing results (161-170 of 228) with videos related to
Sort By:
Pageof 23
Neuropharmacology|July 1, 1995
Therapeutic brain concentration of the NMDA receptor antagonist amantadineJ Kornhuber, G Quack, W Danysz, et al.Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.Wiener Klinische Wochenschrift|January 1, 1993
[Pathology of the central nervous system in AIDS. An overview of 184 patients]M Drlicek, U Liszka, E Wondrusch, et al.Wiener Klinische Wochenschrift|May 30, 1975
[The Moschcowitz syndrome--a rare cause of coma of unknown aetiology (author's transl)]H Pall, K Jellinger, G Kleinberger, et al.Brain : a Journal of Neurology|December 1, 1994
Patterns of oligodendroglia pathology in multiple sclerosisK Ozawa, G Suchanek, H Breitschopf, et al.Acta Neuropathologica|August 15, 1998
Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob diseaseJ A Hainfellner, J Wanschitz, K Jellinger, et al.Wiener Medizinische Wochenschrift (1946)|June 5, 1998
[Epidemiology of transmissible spongiform encephalopathies (prion diseases) in Austria]C Radbauer, J A Hainfellner, K Jellinger, et al.Acta Neuropathologica|January 1, 1995
Cell death in Alzheimer's disease evaluated by DNA fragmentation in situH Lassmann, C Bancher, H Breitschopf, et al.The American Journal of Pathology|November 7, 1999
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell deathC Stadelmann, T L Deckwerth, A Srinivasan, et al.Clinical Chemistry and Laboratory Medicine|December 16, 1998
Activated immune system in patients with Huntington's diseaseF Leblhuber, J Walli, K Jellinger, et al.Pageof 23